Recent Quotes (30 days)

You have no recent quotes
chg | %

Healthcare News

Showing stories 1 - 10 of about 70   
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next ...
PARIS, Feb. 20, 2018 /PRNewswire/ -- Johnson & Johnson Medical Devices Companies, through French affiliate Apsis S.A.S., announced today the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a ...
Johnson & Johnson acquires robotic systems developer Orthotaxy: 5 things ...  Becker's Orthopedic & Spine
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Johnson ...
NEW YORK, Feb. 20, 2018 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) between ...
Berko: Johnson & Johnson has a bright future (and talcum powder is safe)
Dear Mr. Berko: I bought 300 shares of Johnson & Johnson on your recommendation at $106 in April 2017 and have a 23-point profit.
Johnson & Johnson falls on 'disappointing' sales outlook
Shares of Johnson & Johnson turned negative as investors reacted to a lackluster sales growth outlook. The company topped Wall Street's fourth-quarter earnings and revenue expectations with boosts from new cancer drugs and its acquisition of Swiss ...
Johnson & Johnson loses $10.7B after sweeping US tax changes  USA TODAY
Don't Expect a Huge J&J Investment Surge  Bloomberg
Your Daily Pharma Scoop: AbbVie's Upadacitinib, Johnson & Johnson's Tremfya ...
Today we will discuss AbbVie (ABBV), which continues to have a phenomenal run in 2018 even as sentiment on the broader equity market has turned negative.
Iron Deficiency Anemia - Pipeline Insight, 2018 Featuring Johnson & Johnson ...
'Iron Deficiency Anemia - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Iron Deficiency Anemia development.
Johnson & Johnson falls on report that lawsuits could expose potentially ...
Johnson & Johnson's stock fell on a report that court proceedings could expose potentially damaging documents. J&J is facing numerous lawsuits claiming its talc products such as Johnson's Baby Powder caused cancer.
Johnson & Johnson Mesothelioma Trial Likely to Expose Company Documents Blog (blog)
Johnson & Johnson Faces Second Talcum Powder Mesothelioma Trial in New ...  RX Injury Help (press release) (blog)
Does Johnson & Johnson's (NYSE:JNJ) February Stock Price Reflect Its Future ...
Johnson & Johnson (NYSE:JNJ) is considered a high growth stock. However its last closing price of $133.15 left investors wondering whether this growth has already been factored into the share price.
WESPAC Advisors SoCal LLC Has $4.39 Million Stake in Johnson & Johnson (JNJ)  The Ledger Gazette
Lsv Asset Management Stake in Johnson & Johnson (JNJ) Cut by $28.02 ...  BZ Weekly
Why I Recently Bought Johnson & Johnson
Recent earnings have renewed my trust in the company's long term growth plan backed by a strong pipeline that will fuel continued dividend increases.
Johnson & Johnson (JNJ): From Top to Bottom  StockNewsJournal
Telemus Capital LLC Has $3.17 Million Holdings in Johnson & Johnson (JNJ)  The Ledger Gazette
Johnson & Johnson withdraws pelvic mesh device from Australian market
Manufacturers of pelvic or transvaginal mesh devices were asked to update 'instructions for use'. Photograph: Emily Critchfield/Duke Health.
Johnson & Johnson Has Withdrawn The Mesh Products It Is Being Sued Over  BuzzFeed News